|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Colorectal Cancer | |||||
| Prostate Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Colorectal Neoplasms | |||||
| Prostatic Neoplasms | |||||
| 3 | More general conditions related to this trial | ||||
| Colonic Diseases | |||||
| Digestive System Diseases | |||||
| Digestive System Neoplasms | |||||
| Gastrointestinal Diseases | |||||
| Gastrointestinal Neoplasms | |||||
| Genital Diseases, Male | |||||
| Genital Neoplasms, Male | |||||
| Intestinal Diseases | |||||
| Intestinal Neoplasms | |||||
| Neoplasms | |||||
| Neoplasms by Site | |||||
| Prostatic Diseases | |||||
| Rectal Diseases | |||||
| Urogenital Neoplasms | |||||
| 4 | Interventions listed in this trial | ||||
| ascorbic acid | |||||
| beta carotene | |||||
| multivitamin | |||||
| vitamin E | |||||
| 5 | More general drug interventions related to this trial | ||||
| Antioxidants | |||||
| Growth Substances | |||||
| Micronutrients | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| Vitamins | |||||
| 6 | Sponsors listed in this trial | ||||
| Dana-Farber/Brigham and Women's Cancer Center | |||||
| National Cancer Institute (NCI) | |||||